US$ 24.27
exenatide glp 1 agonist PDB-101: Molecule of the Month: GLP-1 Receptor Agonists Treatment with GLP-1 Receptor Agonists
Description
Efficacy and safety of saxagliptin combination therapy in US patients with type 2 diabetes

GAP Analysis 2.5.5

The symptoms of gastroparesis can be debilitating and include severe abdominal pain, persistent nausea, vomiting, bloating, and a feeling of fullness after eating just a small amount of food

Media coverage overlap

Thanks ed silverman for covering Public Citizen contends that Novo Nordisk and Eli Lilly's obesity drugs are straining budgets so much that generics should be authorized.

Cell Metab (2018) 28(2):196206
